1-8 of 8
Marta Rodriguez
Close
Sort by
Journal Articles

Real Life Experience of Brentuximab Vedotin Plus CHP As First-Line Treatment in CD30 + Peripheral T-Cell Lymphomas

Domingo Domenech Eva, Juan-Manuel Sancho, Eva González-Barca, Nicholas Kelleher, Marta Rodriguez-Luaces, Jordina Rovira Sole, Silvia Verdesoto, Maite Encuentra, Damir Blazevic, Ana C Oliveira, Lourdes Escoda, Josep-Maria Ribera, Anna Sureda
Journal: Blood
Blood (2021) 138 (Supplement 1): 4543.
https://doi.org/10.1182/blood-2021-149506
Published: 2021
Journal Articles

Diffuse Large B Cell Lymphoma Genetic Classification By Targeted Sequencing and Associations with Immunochemotherapy-Treated Patients' Clinical Outcome

Lucia Pedrosa Perez, Ismael Fernández-Miranda, David Perez Callejo, Cristina Quero, Marta Rodriguez, Paloma Martin-Acosta, Sagrario Gomez, Julia González-Rincón, Adrian Santos, Carlos Tarin, Juan F. Garcia, Francisco R García-Arroyo, Antonio Rueda, Francisca I Camacho, Monica Garcia-Cosio, MD, Ana Heredero, Marta Llanos, Manuela Mollejo, Miguel Piris-Villaespesa, José Gómez Codina, MD, Natalia Yanguas-Casás, Antonio Sánchez, Miguel A. Piris, Mariano Provencio, Margarita Sanchez-Beato
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-141193
Published: 2020
Journal Articles

Hemorrhage Is a Major Cause of Blood Transfusion in COVID-19 Patients

Cristina Sanz, MDPhD, Anabel Faundez, Registered nurse, Anna García Carulla, Registered nurse, Marta Rodriguez Aliberas, MD, Anny Coromoto, MD, Arturo Pereira, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-138830
Published: 2020
Journal Articles

Proof of Concept for Tipifarnib in Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL) and CXCL12+ Peripheral T-Cell Lymphoma (PTCL): Preliminary Results from an Open-Label, Phase 2 Study

Thomas E. Witzig, MD, Lubomir Sokol, MD PhD, Francine M. Foss, MD, Won-Seog Kim, MD PhD, Eric Jacobsen, MD, Maria de Fatima De La Cruz, MD, Dolores Caballero, MD PhD, Ranjana H Advani, MD, Jose Maria Roncero, MD, Raquel de Oña, Ana Marin Niebla, PhD, Antonia Rodriguez Izquierdo, Maria Jose Terol, Eva Domingo-Domenech, MD, Miguel A. Piris, Marta Rodriguez, James Bolognese, PhD, Linda Kessler, BA, Vishnu Mishra, PhD, Robert Curry, BA, MBA, Michael Kurman, Catherine Scholz, PharmD, Antonio Gualberto, PhD MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 468.
https://doi.org/10.1182/blood-2019-128513
Published: 2019
Journal Articles

SOX11 Regulates Angiogenesis In Mantle Cell Lymphoma

Jara Palomero, Maria Carmela Vegliante, Marta Rodríguez, Ester Planas, Inmaculada Ribera, MD, Maria Cinta Cid, MD, PhD, Elias Campo, MD, PhD, Virginia Amador, PhD
Journal: Blood
Blood (2013) 122 (21): 246.
https://doi.org/10.1182/blood.V122.21.246.246
Published: 2013
Journal Articles

Responsiveness of HIV-specific CD4 T cells to PD-1 blockade

Filippos Porichis, Douglas S. Kwon, Jennifer Zupkosky, Daniel P. Tighe, Ashley McMullen, Mark A. Brockman, David F. Pavlik, Marta Rodriguez-Garcia, Florencia Pereyra, Gordon J. Freeman, Daniel G. Kavanagh, Daniel E. Kaufmann
Journal: Blood
Blood (2011) 118 (4): 965–974.
https://doi.org/10.1182/blood-2010-12-328070
Published: 2011
Includes: Supplemental data
Journal Articles

Liver Infiltration In Splenic Marginal Zone Lymphoma: Prevalence and Prognostic Implication

Eva Domingo-Domenech, Vicente Romagosa, Eva González-Barca, Marta Rodriguez-Aliberas, Ana Oliveira, Esmeralda de la Banda, Santiago Mercadal, Jose Sarra, Jose Petit, Alberto Fernandez de Sevilla, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4137.
https://doi.org/10.1182/blood.V116.21.4137.4137
Published: 2010
Journal Articles

Rapid recovery from T lymphopenia by CD28 superagonist therapy

Karin Elflein, Marta Rodriguez-Palmero, Thomas Kerkau, Thomas Hünig
Journal: Blood
Blood (2003) 102 (5): 1764–1770.
https://doi.org/10.1182/blood-2002-11-3586
Published: 2003